Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Bart Scott
Woman and Man Max 99 years
Bart Scott
Update Il y a 4 ans
Azacitidine and Etanercept in Treating Patients With Myelodysplastic Syndromes
This phase I/II trial studies how well giving azacitidine together with etanercept works in treating patients with myelodysplastic syndromes (MDS). Drugs used in chemotherapy, such as azac...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Bart Scott
Update Il y a 4 ans
Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant
This randomized clinical trial studies different chemotherapies in treating patients with myelodysplastic syndrome before donor stem cell transplant. Giving chemotherapy before a donor ste...
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman and Man Max 99 years
Bart Scott
Update Il y a 4 ans
Azacitidine in Treating Patients With Relapsed Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant
This phase II trial studies how well azacitidine works in treating patients with relapsed myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia (CMML), or acute myeloid leukemia ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Bart Scott
Update Il y a 4 ans
Deferasirox in Treating Patients With Very Low, Low, or Intermediate-Risk Red Blood Cell Transfusion Dependent Anemia or Myelodysplastic Syndrome
This phase II trial studies how well deferasirox works in treating patients with very low, low, or intermediate-risk anemia or myelodysplastic syndrome that depends on red blood cell trans...
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman and Man Max 99 years
Bart Scott
Update Il y a 4 ans
Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
RATIONALE: Giving chemotherapy, such as fludarabine phosphate, busulfan, and cyclophosphamide, and total-body radiation therapy before a donor peripheral stem cell transplant helps stop th...
Country
None
organs
None
Specialty
None
Closed trial
More information